Literature DB >> 9545761

[A case of dural sinus thrombosis during the medication of medroxyprogesterone acetate].

M Hitosugi1, O Kitamura, A Takatsu, K Watanabe, S Kan.   

Abstract

It is reported that medroxyprogesterone acetate (MPA) causes venous thrombosis as one of the side effects. A 49-year-old woman suffering from metastatic lung carcinoma from breast carcinoma was administered MPA 1200 mg/day for about four months. Thereafter she complained of dizziness about two weeks but the general practitioners could detect no abnormality on physical examinations and on brain CT X-ray findings. Six days later, she died suddenly at her home. Forensic autopsy findings revealed the marked superior sagital sinus thrombosis and the malignant lymphadenomatosis caused by metastatic lung carcinoma. As the patient had not disease or trauma causing dural sinus thrombosis except for the administration of MPA, we concluded that superior sagital sinus thrombosis was due to the medication of MPA. This case illustrates that forensic pathologist should consider the major side effect of some drugs like our case.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9545761

Source DB:  PubMed          Journal:  Nihon Hoigaku Zasshi        ISSN: 0047-1887


  3 in total

1.  Retinal venous occlusion associated with depot medroxyprogesterone acetate.

Authors:  Byron F Deen; R Keith Shuler; Sharon Fekrat
Journal:  Br J Ophthalmol       Date:  2007-09       Impact factor: 4.638

2.  Extensive Cerebral Venous Sinus Thrombosis Due to Medroxyprogesterone Acetate.

Authors:  Daniel Barmas-Alamdari; Guneet S Sodhi; Arielle R Spitze
Journal:  Neuroophthalmology       Date:  2020-09-03

3.  Cyclosporin A-related cerebral venous sinus thrombosis: A case report.

Authors:  Fengjuan Gao; Jun Zhang; Fang Wang; Xiaoyan Xin; Dujuan Sha
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.